Concepedia

Author

Akira Sakuma

Tokyo Medical and Dental University

Also Known As

A Sakuma, AKIRA SAKUMA, Akira SAKUMA, Akira Sakuma, Sakuma Akira, akira sakuma

109

Publications

790

Citations

16

H-Index

61

Concepts

All Affiliations

Tokyo Medical and Dental UniversityThe University of TokyoNagoya UniversityTohoku UniversityJichi Medical University
AS

About

Akira Sakuma is an author at Tokyo Medical and Dental University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

12

455

2

Natural Sciences

2

2

107

3

Health Sciences

1

1

21

4

Public Health

1

1

16

5

Social Sciences

1

1

21

Akira Sakuma

×

19

Publications

660

Citations

16

H-Index

YearCitations

Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations

I Sobue, Tetsuya Takayanagi, Takao Nakanishi,

Journal of the Neurological Sciences

1983

94

A Phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer

Kiyoyuki Furuse, Kaoru Kubota, Masaaki Kawahara,

Lung Cancer

1994

81

Carcinoma of the colon and rectum of rats by rectal infusion of N-methyl-N'-nitro-N-nitrosoguanidine.

Tomio Narisawa, T. Sato, Masaru Hayakawa,

PubMed

1971

73

Myotonic dystrophy with alveolar hypoventilation and hypersomnia: a clinicopathological study

Seiitsu Ono, Hiroshi Kurisaki, Akira Sakuma,

Journal of the Neurological Sciences

1995

46

Double‐blind test of human urinary macrophage colony‐stimulating factor for allogeneic and syngeneic bone marrow transplantation: effectiveness of treatment and 2‐year follow‐up for relapse of leukaemia

T Masaoka, Hirotoshi Shibata, Ryuzo Ohno,

British Journal of Haematology

1990

45

Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis

Yukio Fukuyama, Kenji Nihei, Shuzo Matsumoto,

Brain and Development

1987

41

Therapeutic Effect of Ticlopidine, a New Inhibitor of Platelet Aggregation, on Chronic Arterial Occlusive Diseases, a Double-blind Study versus Placebo

Tatsuki Katsumura, Yoshio Mishima, Kisaku Kamiya,

Angiology

1982

40

Clinical pharmacologic evaluation of the antiatherosclerotic agent, pyridinolcarbamate. A double-blind crossover trial in the treatment of atherosclerosis obliterans

Takio Shimamoto, Toshiyuki Atsumi, Sekiya Yamashita,

American Heart Journal

1970

27

Acceleration of DNA synthesis in post-hepatectomized regenerating liver of normal rat by insulin and glucagon

Katsuyoshi Takatsuki, Kenji Fujiwara, Shigeki Hayashi,

Life Sciences

1981

26

A Placebo‐controlled Double‐blind Study of Epalrestat (ONO‐2235) in Patients with Diabetic Neuropathy

Yoshio Gotō, Nigishi Hotta, Y. Shigeta,

Diabetic Medicine

1993

25

Page 1